Abstract:

As we move towards HIV epidemic control in Cameroon, we strive to limit the number of new infections by maintaining on-treatment PWHIV. The emergence of the Covid-19 pandemic may cause interruptions in HIV treatment and slow progression. COVID-19 control measures have caused; the lockdown of businesses, some health services, and imposed work from home, with intimate partners and more people spending longer hours together at home. As a consequence, there is an increased risk of gender-based violence (GBV). GBV can affect adherence to treatment in PWHIV and prevent them from accessing health services. The main objective of the study was to determine the effect of Covid-19 and GBV on the uptake of HIV services by assessing interruptions in treatment. Using a structured questionnaire, demographic data, Information on COVID-19 and intimate partner violence were obtained from 339 participants between 15 and 60 years old, taking HIV treatment at the Touboro district hospital. We used the Antiretroviral treatment register of the health facility to extract data on the frequency and duration of interruption in treatment. The Prevalence of intimate partner violence was high in our study participants, although interruption in treatment was only significant in respondents who reported verbal abuse. A strong association was observed between Covid 19 and interruption in treatment. There was equally an association between Covid-19 and an increase in intimate IPV. Other Socio-demographic variables found to affect interruption in treatment were level of Education of the partner, Age difference with intimate partner greater than 10years, and early years on antiretroviral therapy. According to the study, Both Gender-based violence (IPV) and Covid-19 affect interruption in antiretroviral treatment.

References:

[1] WHO, HIV/AIDS (key facts), Date of access: 29/05/2021. https://www.who.int/news-room/fact-sheets/detail/hiv-aids.

[2] UNAIDS, Global HIV & AIDS statistics- fact sheet, Date of access: 21/03/2021. https://www.unaids.org/en/resources/fact-sheet.

[3] UNAIDS, Global HIV & AIDS statistics- fact sheet, Date of access: 29/05/2021. https://www.unaids.org/en/resources/fact-sheet.

[4] Leddy, A. M., Weiss, E., Yam E., et Pulerwitz, J., 2019, Gender-based violence and engagement in biomedical HIV prevention, care and treatment: a scoping review. BMC Public Health, 19(1), 897 https://doi.org/10.1186/s12889-019-7192-4.

[5] WHO, 2004, Violence Against Women and HIV/AIDS: Critical Intersections - Intimate Partner Violence and HIV/AIDS. Inf. Bull. Ser, 1, 1–9. https://www.who.int/hac/techguidance/pht/InfoBulletinIntimatePartnerViolenceFinal.pdf.

[6] Peltz, A., Reitenauer, E., 2021, Gender Equality and Gender-based Violence Prevention & Response Services in USAID’s PEPFAR Programs. Intra Health. https://www.intrahealth.org/sites/ihweb/files/asap-attachment-files/asapwebinargegbvpreventionandresponseservicesinusaidspepfarprograms-updated22321.pdf.

[7] WHO, 2013, 16 Ideas for addressing violence against women in the context of the HIV epidemic: a programming tool. World Health Organization, ISBN 978 92 4 150653 3.

[8] UN WOMEN, Covid-19: Emerging gender data and why it matters, Date of access: 09/05/2021. https://data.unwomen.org/resources/Covid-19-emerging-gender-data-and-why-it-matters.

[9] PEPFAR, 2020, PEPFAR Technical Guidance in Context of Covid-19 Pandemic, state.gov, 1–8. https://www.state.gov/wp-content/uploads/2020/10/10.07.2020-PEPFAR-Technical-Guidance-During-Covid.pdf.

[10] Chenneville, T., Gabbidon, K., Hanson, P., et Holyfield, C., 2020, The Impact of Covid-19 on HIV Treatment and Research: A Call to Action. Int. J. Environ. Res. Public Health, 17(12), 4548, 1-14. https://doi.org/10.3390/ijerph17124548.

[11] WHO, Weekly epidemiological update on Covid-19 - 27 April 2021,

[12] Date of access: 09/05/2021. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-Covid-19---27-april-2021.

[13] WHO, Cameroon: WHO Coronavirus Disease (Covid-19) Dashboard, Date of access: 31/01/201. https://Covid19.who.int/region/afro/country/cm.

[14] Judson, S. D., Njabo, K. Y., et Torimiro, J. N., 2020, Regional vulnerability for Covid-19 in Cameroon. The Pan African medical journal, 37(Suppl 1), 16. https://doi.org/10.11604/pamj.supp.2020.37.16.26167.

[15] Marzo, R. R., Singh, A., et Mukti, R. F., 2021, A survey of psychological distress among Bangladeshi people during the Covid-19 pandemic.Clinical Epidemiology and Global Health. Elsevier, 10, p. 100693. DOI: 10.1016/J.CEGH.2020.100693.

[16] Cooper, T. J., Woodward, B. L., Alom, S., et Harky, A., 2020, Coronavirus disease 2019 (Covid-19) outcomes in HIV/AIDS patients: a systematic review. HIV medicine, 21(9), 567–577. https://doi.org/10.1111/hiv.12911.

[17] Kamberi, F. et al., 2021, Impact of Covid-19 pandemic on mental health, risk perception and coping strategies among health care workers in Albania - evidence that needs attention, Clinical Epidemiology and Global Health. Elsevier, 12, 100824. DOI: 10.1016/J.CEGH.2021.100824.

[18] El-Abasiri, R. A. et al., 2020, Evaluating the psychological distress of the coronavirus disease 2019 pandemic in Egypt, European Journal of Molecular and Clinical Medicine, 7(5), 1–12. Available at: https://www.embase.com/search/results?subaction=viewrecord&id=L2010164833&from=export.

[19] Htay, M. N., et al., 2021 , How healthcare workers are coping with mental health challenges during Covid-19 pandemic? - A cross-sectional multi-countries study, Clinical Epidemiology, and Global Health. Elsevier B.V., 11(February), 100759. DOI: 10.1016/j.cegh.2021.100759.

[20] UNAIDS, Covid-19, and HIV: 1 moment, 2 epidemics, 3 opportunities—how to seize the moment to learn, leverage, and build a new way forward for everyone’s health and rights, Date of access: 09/05/2021. https://www.unaids.org/en/resources/documents/2020/20200909_lessons_hiv_Covid.

[21] Fiorentino, M., Sagaon-Teyssier, L., Ndiaye, K., Suzan-Monti, M., Mengue, M. T., Vidal, L., Kuaban, C., March, L., Laurent, C., Spire, B., Boyer, S., et EVOLCam Study Group, 2019, Intimate partner violence against HIV-positive Cameroonian women: Prevalence, associated factors, and relationship with antiretroviral therapy discontinuity-results from the ANRS-12288 EVOLCam survey. Women’s health (London, England), 15, 1745506519848546. https://doi.org/10.1177/1745506519848546.

[22] Kapiga, S., Harvey, S., Muhammad, A. K., Stöckl, H., Mshana, G., Hashim, R., Hansen, C., Lees, S., et Watts, C., 2017, Prevalence of intimate partner violence and abuse and associated factors among women enrolled into a cluster randomised trial in northwestern Tanzania. BMC public health, 17(1), 190. https://doi.org/10.1186/s12889-017-4119-9.

[23] Karakurt, G., Silver, K. E., 2013, Emotional abuse in intimate relationships: the role of gender and age. Violence and Victims, 28(5), 804–821. https://doi.org/10.1891/0886-6708.vv-d-12-00041.

[24] Fiorentino, M., Sagaon-Teyssier, L., Ndiaye, K., Suzan-Monti, M., Mengue, M. T., Vidal, L., Kuaban, C., March, L., Laurent, C., Spire, B., Boyer, S., et EVOLCam Study Group, 2019, Intimate partner violence against HIV-positive Cameroonian women: Prevalence, associated factors, and relationship with antiretroviral therapy discontinuity-results from the ANRS-12288 EVOLCam survey. Women’s health (London, England), 15, 1745506519848546. https://doi.org/10.1177/1745506519848546.

[25] Humanitarian Response, Cameroon: South West Region GBV Rapid assessment – Key findings, January 2019, Date of access: 30/09/2021 https://www.humanitarianresponse.info/en/operations/cameroon/document/cameroon-south-west-region-gbv-rapid-assessment-–-key-findings-January.

[26] Dlamini, P. S., Kohi, T. W., Uys, L. R., Phetlhu, R. D., Chirwa, M. L., Naidoo, J. R., Holzemer, W. L., Greeff, M., et Makoae, L. N., 2007, Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African countries. Public health nursing (Boston, Mass.), 24(5), 389–399. https://doi.org/10.1111/j.1525-1446.2007.00649.x.

[27] Global Campus of Human Rights, Mitigating the Impact of Covid-19 on HIV Responses in Africa - Global Campus of Human Rights, Date of access: 30/09/2021. https://gchumanrights.org/preparedness/article-on/mitigating-the-impact-of-Covid-19-on-hiv-responses-in-africa.html.

[28] WHO, WHO warns that HIV infection increases the risk of severe and critical Covid-19, Date of
access: 30/09/2021. https://www.who.int/news/item/15-07-2021-who-warns-that-hiv-infection-increases-risk-of-severe-and-critical-Covid-19.

[29] Waite, K. R., Paasche-Orlow, M., Rintamaki, L. S., Davis, T. C., et Wolf, M. S., 2008, Literacy, social stigma, and HIV medication adherence. Journal of general internal medicine, 23(9), 1367–1372. https://doi.org/10.1007/s11606-008-0662-5.

[30] UN WOMEN, Covid-19 and ending Violence Against Women and Girls, Date of access: 30/09/2021. https://www.unwomen.org/en/digital-library/publications/2020/04/issue-brief-Covid-19-and-ending-violence-against-women-and-girls.

[31] Aye, S. S., et Rillera, M. R., 2020, Readiness for inter-professional education at health sciences: A study of educational technology prespective, World Journal on Educational Technology: Current Issues, 12(3), 207–216. doi: 10.18844/wjet.v%vi%i.4992.

[32] Soe, S., 2020, Cypriot Journal of Educational Readiness for interprofessional education amongst students at public and private Medical Universities in Malaysia, 15(6), 1454–1463.